TL;DR: Menten AI is a Y Combinator Winter 2020 startup designs peptide and protein therapeutics using quantum…, currently active with a team of 2.
Menten AI designs peptide and protein therapeutics using quantum…
Last verified:
Menten AI designs protein drugs and enzymes using quantum computing and machine learning. Their technology leapfrogs current computational methods making it possible to design previously intractable proteins. The team created the first protein design algorithm for current and near-term quantum computers and created the world’s first protein designed on a quantum computer. They are now working on 3 new proteins, including a peptide to prevent the spread of viruses like Covid-19. They have 2 paid pilot projects with multinational chemical companies and 4 LOI’s with pharma and biotech companies.
Built by LemStudio
Yes. Menten AI was funded by Y Combinator in the Winter 2020 batch. Menten AI designs peptide and protein therapeutics using quantum…
Menten AI designs protein drugs and enzymes using quantum computing and machine learning. Their technology leapfrogs current computational methods making it possible to design previously intractable proteins. The team created the first protein design algorithm for current and near-term quantum computers and created th…
Menten AI was part of Y Combinator's Winter 2020 batch.
Menten AI has a team of 2 people according to Y Combinator's directory.
Menten AI is currently listed as Active with a team of 2 in Y Combinator's directory.
Loading interactive view…